INS and obesity disorder: Therefore, therapeutic strategies targeting inflammation, particularly the pathways involved in caspase-1 activation—a key component of inflammasome activity—could represent a potential strategy to mitigate the chronic inflammation associated with obesity and improve insulin sensitivity [30].